Malaria in pregnancy preventive treatment trial completes recruitment of women

Published on 3 February 2012 in 'Press Releases'

A major milestone in the Malaria in Pregnancy (MiP) field was reached as one of the EDCTP-funded MiP studies completed recruitment. By January 2012, the study had enrolled a total of 4,734 pregnant women in January 2012, after screening 17,947 women ...

Read more »

REMox TB treatment trial completes enrolment

Published on 1 February 2012 in 'Press Releases'

TB Alliance announced today that the enrolment of volunteers in the global REMox TB clinical trial has been completed in January 2012. This is a momentous step forward in the study which aims to establish the efficacy of a possible new drug against t...

Read more »

NIAID expands TB vaccine candidate AERAS-402/Crucell Ad35 clinical trial

Published on 1 February 2012 in 'Announcements'

The National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH) joins the TB vaccine candidate AERAS-402/Crucell Ad35 clinical trial as a partner. Following a new policy NIH is leveragi...

Read more »

EU Commissioner Máire Geoghegan-Quinn discussed EDCTP with Bill Gates

Published on 25 January 2012 in 'Press Releases'

Poverty-related diseases and the European and Developing Countries Clinical Trials Partnership were discussed by Máire Geoghegan-Quinn, EU Commissioner for Research, Innovation and Science, with Mr Bill Gates, Co-Chair of the Bill & Melinda Gates Fou...

Read more »

TBVI Symposium: Europe and ACP together against tuberculosis

Published on 25 January 2012 in 'Announcements'

On the occasion of the World Tuberculosis Day on 22 March 2012, the Tuberculosis Vaccine Initiative (TBVI) will hold the symposium ‘Europe and ACP together against tuberculosis’ in Brussels. Under the patronage of MEP Charles Goerens, and co-hosted b...

Read more »

Simplified artesunate regimen found efficacious in treating children with severe malaria

Published on 20 December 2011 in 'Announcements'

A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard longer regimen. The EDCTP-funded SMAC phase II studies, coordinated by Prof. Peter G. Kremsner, have shown that three doses over two days of the drug ...

Read more »

New call for proposals: EDCTP Strategic Primer grants

Published on 12 December 2011 in 'Announcements'

This grant will provide funding for research groups in sub-Saharan Africa and Europe to conduct innovative, ambitious studies that will generate results to inform future clinical trials; sustain and strengthen the capacity built up under EDCTP I; and...

Read more »

WHO ‘rainbow tables’ on malaria vaccine projects updated

Published on 2 December 2011 in 'Announcements'

The World Health Organisation – Initiative for Vaccine Research (IVR) has published an update of its malaria ‘rainbow’ tables, an overview of malaria vaccine projects on 28 November 2011. The information is collected with the help of malaria vaccine ...

Read more »

World AIDS Day – 1 December 2011: EDCTP-funded research towards prevention and treatment of HIV/AIDS

Published on 1 December 2011 in 'Press Releases'

Every year, World AIDS Day provides an opportunity to raise awareness of the HIV-epidemic and report on global efforts to alleviate the burden of this infection. Recent reports showed a decrease in the number of deaths from AIDS-related illness and n...

Read more »

NACCAP’s Lessons learned available on website

Published on 28 November 2011 in 'Announcements'

The Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) published an introduction to its projects, most of which were funded in partnership with EDCTP, with a summary of the le...

Read more »